Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
19 mai 2021 06h00 HE
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Announces Pricing of Initial Public Offering
08 avr. 2021 21h42 HE
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
REN001 Granted Fast Track Designation by FDA for Patients with Primary Mitochondrial Myopathies
24 mars 2021 08h00 HE
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
Reneo Pharmaceuticals Appoints Vineet R. Jindal as Chief Financial Officer
22 mars 2021 08h00 HE
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
Reneo Pharmaceuticals Appoints Eric Dube, Ph.D. to its Board of Directors
15 mars 2021 08h00 HE
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...